enVVeno Medical Corporation Warrants
NVNOW
NVNOW was delisted on the 26th of May, 2023.
3 hedge funds and large institutions have $5K invested in enVVeno Medical Corporation Warrants in 2021 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
58% less capital invested
Capital invested by funds: $12K → $5K (-$7K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$2.93K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $3K | -$2.93K | -11,513 | -47% |
|
|
PAG
2
Private Advisor Group
Morristown,
New Jersey
| $2K | – | – | – |
|
NVNOW Hedge Fund Activity: Q2 2021 in Review
3 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical Corporation Warrants (NVNOW) for Q2 2021, worth a combined $5K — down 58% from $12K a quarter earlier.
Fund positioning in NVNOW was balanced in Q2 2021: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was UBS Group, cutting an estimated $2.93K.
- 3 institutional investors held enVVeno Medical Corporation Warrants (NVNOW) as of Q2 2021, unchanged from Q1 2021.
- Funds reported $5K of enVVeno Medical Corporation Warrants stock for Q2 2021, down 58% quarter-over-quarter.
- 0 funds opened new enVVeno Medical Corporation Warrants positions in Q2 2021 and 0 closed out.
- The largest enVVeno Medical Corporation Warrants seller in Q2 2021 was UBS Group, an estimated $2.93K sold.
Based on aggregated 13F filings for Q2 2021.